He aha ʻo Mogamulizumab: Nā hoʻohana, ka lāʻau, nā hopena ʻaoʻao a me nā mea hou aku

He lāʻau lapaʻau maʻi maʻi kūikawā ʻo Mogamulizumab e kuhikuhi ana i nā ʻano maʻi koko. He monoclonal antibody ia e hana ana ma ka hoʻopili ʻana i nā sela maʻi a kōkua i kāu ʻōnaehana pale e luku iā lākou. Hoʻohana nui ʻia kēia lāʻau lapaʻau no kekahi mau ʻano lymphoma laha ʻole i pane ʻole i nā lāʻau lapaʻau ʻē aʻe.

He aha ʻo Mogamulizumab?

He lāʻau lapaʻau maʻi maʻi i manaʻo ʻia ʻo Mogamulizumab e pili ana i kahi papa o nā lāʻau i kapa ʻia ʻo monoclonal antibodies. E noʻonoʻo iā ia he missile alakaʻi e ʻimi a hoʻopili i nā protein kikoʻī i loaʻa ma nā sela maʻi. Ke hoʻopili ʻia, hōʻailona ia i kāu ʻōnaehana pale e hoʻouka a luku i kēia mau sela ʻino.

Hāʻawi ʻia kēia lāʻau lapaʻau ma o ka intravenous (IV) infusion, ʻo ia hoʻi, hāʻawi pololei ʻia i loko o kou kahe koko ma o ka vein. Hāʻawi ʻia ka lāʻau lapaʻau i loko o kahi haukapila a i ʻole ke kikowaena lapaʻau maʻi maʻi kūikawā ma lalo o ka mālama olakino. E nānā pono kāu hui mālama ola iā ʻoe i ka wā a ma hope o kēlā me kēia infusion.

No ke aha e hoʻohana ʻia ai ʻo Mogamulizumab?

Ua ʻae ʻia ʻo Mogamulizumab e mālama i ʻelua ʻano lymphoma T-cell laha ʻole. ʻO kēia nā maʻi e pili ana i kahi ʻano keʻokeʻo koko i kapa ʻia ʻo T-cells, he ʻāpana nui o kāu ʻōnaehana pale.

Hoʻohana ʻia ka lāʻau lapaʻau no ka mycosis fungoides a me ka maʻi ʻo Sézary, ʻelua ʻano o ka cutaneous T-cell lymphoma (CTCL). Hoʻomaka pinepine kēia mau maʻi ma ke ʻano he pilikia ʻili akā hiki ke laha i nā ʻāpana ʻē aʻe o ke kino. E ʻōlelo maʻamau kāu kauka iā mogamulizumab ke hana ʻole nā lāʻau lapaʻau ʻē aʻe a i ʻole i ka wā i hoʻi mai ai kou maʻi ma hope o ka lāʻau lapaʻau mua.

He mea nui e maopopo he mau maʻi laha ʻole kēia, a ua manaʻo ʻia ʻo mogamulizumab he lāʻau lapaʻau kūikawā. E loiloi pono kāu kauka oncological inā he koho kūpono kēia lāʻau lapaʻau no kou kūlana kikoʻī e pili ana i kāu mōʻaukala olakino a me ke kūlana olakino o kēia manawa.

Pehea e Hana ai ʻo Mogamulizumab?

Hana ʻo Mogamulizumab ma ka ʻimi ʻana i kahi protein kikoʻī i kapa ʻia ʻo CCR4 i loaʻa ma ka ʻili o kekahi mau pūnaewele maʻi ʻaʻai. Hana kēia protein e like me ka hōʻailona helu wahi e hiki ai i ka lāʻau lapaʻau ke ʻike a paʻa. Ke hoʻopili ʻo mogamulizumab i kēia mau pūnaewele maʻi ʻaʻai, hoʻomaka ia i kāu ʻōnaehana pale e luku iā lākou.

Ua manaʻo ʻia he lāʻau lapaʻau ikaika a kuhikuhi nui ʻia no ka mea ua hoʻolālā ʻia e hoʻouka i nā pūnaewele maʻi ʻaʻai kikoʻī me ka waiho ʻana i nā pūnaewele olakino me ka hoʻopā ʻole ʻia. Eia naʻe, loaʻa nō i kekahi mau pūnaewele maʻamau ka protein CCR4, hiki ke alakaʻi i nā hopena ʻaoʻao. Hoʻohana nui ka lāʻau lapaʻau i ka ʻōnaehana pale maoli o kou kino e hakakā i ka maʻi ʻaʻai me ka ʻoi aku ka maikaʻi.

Hiki i ke kaʻina hana lapaʻau ke lawe i kekahi mau mahina, a ʻaʻole paha ʻoe e ʻike i nā hopena koke. Pono nā pūnaewele maʻi ʻaʻai i ka manawa e pane i ka lāʻau lapaʻau, a e nānā kāu hui lapaʻau i kou holomua ma o nā hoʻokolohua koko maʻamau a me nā haʻawina kiʻi.

Pehea e Lawe ai au i ka Mogamulizumab?

Hāʻawi mau ʻia ʻo Mogamulizumab ma ke ʻano he infusion intravenous i loko o kahi hoʻonohonoho lāʻau lapaʻau, ʻaʻole loa ma ke ʻano he pila āu e lawe ai ma ka home. E hoʻokomo kāu hui mālama ola i kahi paipu liʻiliʻi i loko o kahi vein i kou lima a i ʻole ma o kahi laina waena inā loaʻa iā ʻoe. Lawe maʻamau ka infusion ma kahi o hoʻokahi hola e hoʻopau ai.

Ma mua o kēlā me kēia lapaʻau, e loaʻa iā ʻoe nā lāʻau lapaʻau ma mua e kōkua ai i ka pale ʻana i nā hopena maʻi. Hiki i kēia mau mea ke komo i nā antihistamines, steroids, a i ʻole nā mea hoʻemi wela. ʻAʻole pono ʻoe e hoʻokē ʻai ma mua o ka lapaʻau, akā maikaʻi ke ʻai i ka meaʻai māmā ma mua e kōkua ai i ka pale ʻana i ka nausea. E noho maikaʻi i ka wai ma ka inu ʻana i ka wai nui i nā lā ma mua o kāu infusion.

Pono ʻoe e hoʻolālā e hoʻolilo i kekahi mau hola ma ke kikowaena lapaʻau no kēlā me kēia kipa. Aia kēia i ka manawa no ka hoʻomākaukau, ka hoʻokomo maoli ʻana, a me ka nānā ʻana ma hope. Lawe mai i nā lole ʻoluʻolu, nā mea leʻaleʻa e like me nā puke a i ʻole nā papa, a e noʻonoʻo e loaʻa i kekahi e hoʻokele iā ʻoe i ka home ma hope o ka lapaʻau.

Pehea ka lōʻihi e lawe ai au i ka Mogamulizumab?

ʻO ka papa hana lapaʻau maʻamau e pili ana i ka loaʻa ʻana o ka mogamulizumab i hoʻokahi manawa i ka pule no nā pule 4 mua, a laila i kēlā me kēia 2 pule no nā mahina 4 e hiki mai ana. Ma hope o kēlā, e loaʻa iā ʻoe i hoʻokahi manawa i ka mahina no ka lōʻihi o 2 mau makahiki, ma muli o ka maikaʻi o kāu pane ʻana i ka lapaʻau.

E loiloi mau kāu kauka i ke ʻano o ka pane ʻana o kāu maʻi maʻi ma o nā hoʻokolohua koko, nā kiʻi kiʻi, a me nā hoʻokolohua kino. Inā hana maikaʻi ka lāʻau a ke ʻae nei ʻoe iā ia, hiki iā ʻoe ke hoʻomau i ka lapaʻau no ka lōʻihi piha. Eia naʻe, inā e ulu nā hopena ʻaoʻao koʻikoʻi a i ʻole e pau ka pane ʻana o kāu maʻi maʻi, hiki i kāu kauka ke hoʻololi i ka papa hana a i ʻole e hoʻololi i kahi lapaʻau ʻē aʻe.

He mea nui e mālama i nā manawa i hoʻonohonoho ʻia, ʻoiai inā maikaʻi ʻoe. ʻO ka haʻalele ʻana i nā lapaʻau hiki ke hōʻemi i ka pono o ka lāʻau a hiki i nā cell maʻi maʻi ke ulu hou. Inā pono ʻoe e hoʻopaneʻe i kahi lapaʻau ma muli o ka maʻi a i ʻole nā hopena ʻaoʻao, e hana pū kāu hui lapaʻau me ʻoe e hoʻoholo i ka manawa maikaʻi loa.

He aha nā hopena ʻaoʻao o Mogamulizumab?

E like me nā lapaʻau maʻi maʻi a pau, hiki i ka mogamulizumab ke hana i nā hopena ʻaoʻao, ʻoiai ʻaʻole i loaʻa nā mea a pau iā lākou. Hiki ke mālama ʻia ka hapa nui o nā hopena ʻaoʻao me ka mālama olakino kūpono a me ka nānā ʻana. E kūkākūkā kāu hui mālama ola i ka mea e manaʻo ai a pehea e mālama ai i nā pilikia e kū mai ana.

ʻO nā hopena ʻaoʻao maʻamau e hiki iā ʻoe ke ʻike, ʻo ia nā hopena ʻili, ka luhi, a me ka piʻi ʻana o ka pilikia o nā maʻi. Eia nā hopena ʻaoʻao e pono ai ʻoe e ʻike:

Nā hopena ʻaoʻao maʻamau (e hana ana ma mua o 20% o nā maʻi)

• He maʻi ʻili a i ʻole ka ʻūlū
• Luhi a me ka nāwaliwali
• Pāpaʻa
• Nā maʻi hanu luna
• ʻEha ʻiʻo a me nā hui
• Ka pehu ʻana ma nā lima, nā wāwae, a i ʻole ka maka
• Liva
• Hoʻēmi ʻia ka ʻai

He maʻamau kēia mau hopena ʻaoʻao, mai ke akahai a i ke kūpono, a pinepine e hoʻomaikaʻi ke hoʻololi kou kino i ka lāʻau. Hiki i kāu hui lapaʻau ke hāʻawi i nā lāʻau a me nā hoʻolālā e kōkua i ka mālama ʻana i kēia mau hōʻailona me ka pono.

Nā Hopena ʻAoʻao Kūlana (ʻAʻole maʻamau akā pono e mālama koke ʻia)

ʻOiai he mea maʻamau ʻole, pono kekahi mau hopena ʻaoʻao i ka mālama olakino koke. E kelepona koke i kāu mea mālama ola inā ʻike ʻoe i kekahi o kēia mau hōʻailona:

• Nā hopena ʻili koʻikoʻi me ka ʻōhū a i ʻole ka ʻili ʻana
• Nā hōʻailona o ka maʻi koʻikoʻi (liva kiʻekiʻe, nā anu, ka ʻūlū mau)
• He paʻakikī ka hanu ʻana a i ʻole ka ʻeha o ka umauma
• Pāpaʻa koʻikoʻi me ke koko
• Ke kahe koko a i ʻole ka ʻeha maʻamau ʻole
• Luhi koʻikoʻi e pale ana i nā hana o kēlā me kēia lā

E nānā pono kāu hui lapaʻau iā ʻoe no kēia mau hopena ʻaoʻao koʻikoʻi ma o nā hoʻokolohua koko maʻamau a me nā hoʻokolohua kino. Hiki i ka ʻike mua a me ka mālama ʻana i nā hopena ʻaoʻao ke pale iā lākou mai ka lilo ʻana i nā pilikia koʻikoʻi.

Nā Hopena ʻAoʻao Kūlana ʻole akā Kūlana

I nā hihia maʻamau loa, hiki i ka mogamulizumab ke hana i nā pilikia koʻikoʻi e pono ai ka hana lapaʻau koke. Pākuʻi ʻia kēia mau mea i nā hopena autoimmune koʻikoʻi kahi e hoʻouka ai kou ʻōnaehana pale i nā ʻōkana olakino, nā pilikia puʻuwai koʻikoʻi, a i ʻole nā hopena neurological koʻikoʻi. ʻOiai he mea maʻamau ʻole kēia mau pilikia, e nānā kāu hui lapaʻau i nā hōʻailona mua a hana wikiwiki inā kū mai kekahi hopohopo.

ʻO wai ka mea pono ʻole e lawe i ka Mogamulizumab?

ʻAʻole kūpono ka Mogamulizumab no nā mea a pau, a e loiloi pono kāu kauka inā palekana ia nāu. ʻAʻole kūpono paha nā kānaka me kekahi mau maʻi olakino a i ʻole nā kūlana no kēia lapaʻau.

ʻAʻole pono ʻoe e loaʻa i ka mogamulizumab inā he maʻi maʻi koʻikoʻi kou i ka lāʻau a i ʻole kekahi o kāna mea i loko. E akahele nō hoʻi kāu kauka i ka ʻōlelo ʻana inā he maʻi koʻikoʻi kou e hana nei, ʻaʻole i mālama pono ʻia, no ka mea, hiki i ka lāʻau ke kāohi i kou ʻōnaehana pale a hoʻonui i nā maʻi.

Pili nā manaʻo kūikawā i kekahi mau pūʻulu o nā kānaka:

• Nā wāhine hāpai (hiki i ka lāʻau ke hōʻino i ka pēpē e ulu ana)
• Nā kānaka me ka maʻi puʻuwai koʻikoʻi
• ʻO ka poʻe me nā maʻi autoimmune e hana nei
• Nā kānaka me nā pilikia ate a i ʻole nā pilikia kīkī
• ʻO ka poʻe i loaʻa i kekahi mau lāʻau lapaʻau i kēia manawa

E nānā kāu kauka i kāu moʻolelo olakino piha, nā lāʻau lapaʻau e hana nei, a me ke kūlana olakino holoʻokoʻa ma mua o ka hoʻoholo ʻana inā kūpono ka mogamulizumab iā ʻoe. Kōkua kēia loiloi piha e hōʻoia e loaʻa iā ʻoe ka lāʻau palekana a me ka maikaʻi loa.

Mogamulizumab inoa inoa

Kūʻai ʻia ka Mogamulizumab ma lalo o ka inoa inoa ʻo Poteligeo. Hoʻohana ʻia kēia inoa inoa ma ʻAmelika Hui Pū ʻIa a me nā ʻāina ʻē aʻe he nui. Hiki iā ʻoe ke ʻike i kēia inoa ma kāu mau moʻolelo olakino, nā palapala ʻinikua, a i ʻole nā papa hana lapaʻau.

Hana ʻia ka lāʻau e Kyowa Kirin, kahi hui lāʻau lapaʻau e loea ana i nā lāʻau lapaʻau maʻi ʻaʻai. Ke kūkākūkā ʻana i kāu lapaʻau me nā mea mālama ola a i ʻole nā hui ʻinikua, hiki iā ʻoe ke kuhikuhi iā ia ma kekahi inoa - mogamulizumab a i ʻole Poteligeo.

Nā koho ʻē aʻe o Mogamulizumab

Nui nā koho lapaʻau ʻē aʻe no ka lymphoma T-cell cutaneous, ʻoiai e hilinaʻi ka koho i kou kūlana kikoʻī a me ka mōʻaukala olakino. E noʻonoʻo kāu oncologist i nā mea e like me kou olakino holoʻokoʻa, nā lapaʻau mua, a me ka holomua o kāu maʻi maʻi i ke kūkākūkā ʻana i nā koho ʻē aʻe.

ʻO nā lāʻau lapaʻau ʻē aʻe i manaʻo ʻia no CTCL e komo pū ana me brentuximab vedotin (Adcetris), e manaʻo ana i kahi protein ʻokoʻa ma nā pūnaewele maʻi ʻaʻai. Hiki nō hoʻi nā lāʻau lapaʻau chemotherapy kuʻuna e like me gemcitabine a i ʻole pegylated liposomal doxorubicin. Eia kekahi, hiki ke kūpono nā lapaʻau e like me ka radiation therapy, phototherapy, a i ʻole nā lāʻau lapaʻau topical ma muli o kou kūlana.

Loaʻa i kēlā me kēia koho ʻē aʻe kona mau pono a me nā hopena ʻaoʻao. E kōkua kāu hui lapaʻau iā ʻoe e loiloi i kēia mau koho a koho i ke ala lapaʻau e hāʻawi ana i ka manawa maikaʻi loa o ka holomua me ka noʻonoʻo ʻana i kou maikaʻi o ke ola a me nā makemake pilikino.

ʻOi aku ka maikaʻi o Mogamulizumab ma mua o nā lapaʻau CTCL ʻē aʻe?

Ua hōʻike ʻo Mogamulizumab i nā hopena maikaʻi i nā hoʻokolohua lapaʻau, ʻoi aku hoʻi no ka poʻe i hoʻi mai kā lākou maʻi maʻi ma hope o nā lapaʻau ʻē aʻe. Hōʻike nā haʻawina e hiki ke kōkua i ka mālama ʻana i ka maʻi no ka lōʻihi ma mua o kekahi mau ala chemotherapy kuʻuna, me ka liʻiliʻi o nā hopena ʻaoʻao koʻikoʻi.

Eia naʻe,

Inā he maʻi puʻuwai kou, pono paha ʻoe i ka nānā ʻana i ka puʻuwai hou aʻe i ka wā o ka mālama ʻana, me nā electrocardiograms maʻamau a me nā echocardiograms. Hiki i kāu hui lapaʻau ke hoʻoponopono i ka papa hana lapaʻau a i ʻole ka nui o ka lāʻau lapaʻau ma muli o ke ʻano o ka pane ʻana o kou puʻuwai i ka lāʻau.

Q2. He aha kaʻu e hana ai inā loaʻa iaʻu ka nui o ka Mogamulizumab?

No ka mea, hāʻawi ʻia ka mogamulizumab i nā wahi lapaʻau e nā poʻe loea i aʻo ʻia, he mea maʻamau loa ka nui o ka lāʻau lapaʻau. Ana ʻia ka lāʻau lapaʻau a hāʻawi ʻia ma lalo o nā protocols paʻa. Eia naʻe, inā manaʻo ʻoe ua hana hewa ʻia i ka wā o kāu infusion, e hoʻomaopopo koke i kāu hui mālama ola.

Inā hāʻawi ʻia ka nui o ka lāʻau lapaʻau, e nānā pono ʻia ʻoe no ka hoʻonui ʻia ʻana o nā hopena ʻaoʻao, ʻoi aku ka nui o nā hopena ʻili a me nā hōʻailona o ka hoʻopaʻa ʻana i ka ʻōnaehana pale. Loaʻa i kāu hui lapaʻau nā protocols e mālama i nā pilikia e hiki mai ana mai nā hewa dosing.

Q3. He aha kaʻu e hana ai inā ua hala wau i kahi mahele o Mogamulizumab?

Inā ua hala ʻoe i kahi infusion i hoʻonohonoho ʻia, e hoʻokaʻaʻike i kāu hui mālama ola i ka hiki wawe e hoʻonohonoho hou. Mai kali a hiki i kāu manawa i hoʻonohonoho ʻia e hiki mai ana, no ka mea, he mea nui ka mālama ʻana i ka papa hana lapaʻau no ka pono o ka lāʻau.

E hoʻoholo kāu kauka i ka manawa maikaʻi loa no kāu mahele makeup ma muli o ka lōʻihi o ka hala ʻana mai kāu manawa i hala a me kāu hoʻolālā lapaʻau holoʻokoʻa. I kekahi mau hihia, hiki iā ʻoe ke loaʻa ka mahele i hala i loko o kekahi mau lā, ʻoiai nā kūlana ʻē aʻe e koi ai i ka hoʻoponopono ʻana i kāu papa hana holoʻokoʻa.

Q4. I ka manawa hea e hiki ai iaʻu ke hooki i ka lawe ʻana i ka Mogamulizumab?

ʻO ka hoʻoholo e hooki i ka mogamulizumab e pili ana i nā mea he nui, me ka maikaʻi o ka pane ʻana o kāu maʻi maʻi, nā hopena ʻaoʻao āu e ʻike nei, a me kou kūlana olakino holoʻokoʻa. Hoʻomau ka hapa nui o nā maʻi i ka mālama ʻana a hiki i 2 mau makahiki inā e pane maikaʻi ana lākou a me ka hoʻomanawanui ʻana i ka lāʻau.

E loiloi mau kāu kauka i kou holomua ma o nā scans, nā hoʻokolohua koko, a me nā hoʻokolohua kino. Inā aia kou maʻi 'aʻai i ke kala ʻana a ke kāohi ʻia nei, hiki paha iā ʻoe ke hooki i ka lapaʻau. Akā, mai hooki loa i ka lāʻau lapaʻau ma kou iho, no ka mea, hiki i kēia ke ʻae i kou maʻi 'aʻai e hoʻi mai a i ʻole e holomua.

Q5. Hiki iaʻu ke loaʻa nā lāʻau lapaʻau i ka wā e lawe ana i ka Mogamulizumab?

Hoʻopilikia ka Mogamulizumab i kou ʻōnaehana pale, no laila pono ka hoʻolālā pono ʻana i ka manawa o ka lāʻau lapaʻau. Pono e pale ʻia nā lāʻau lapaʻau ola (e like me ka MMR a i ʻole ka lāʻau lapaʻau chickenpox) i ka wā e loaʻa ana iā ʻoe ka lapaʻau, no ka mea, hiki iā lākou ke hoʻoulu i nā maʻi koʻikoʻi i ka poʻe me nā ʻōnaehana pale i hoʻopaʻa ʻia.

ʻOi aku ka palekana o nā lāʻau lapaʻau i hoʻopau ʻia (e like me ka pana flu) akā ʻaʻole paha e hana maikaʻi i ka wā e loaʻa ana iā ʻoe ka lapaʻau. E hana pū kāu hui mālama ola me ʻoe e hoʻoholo i ka manawa maikaʻi loa no nā lāʻau lapaʻau e pono ai, e hāʻawi ana iā lākou ma mua o ka hoʻomaka ʻana i ka lapaʻau a i ʻole i ka wā hoʻomaha lapaʻau i ka wā i ola ai kou ʻōnaehana pale.